Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.
Source facts
Action
Affected consignees were notified by phone on August 3, 2026.
Customers were informed that as a precaution, Baxter would replace impacted VOLARA devices. A Baxter clinical trainer would contact the customers to schedule a home visit to exchange the device. Customers were asked to continue to use the VOLARA device as prescribed until it was exchanged.
As of August 13, 2026, all potentially affected devices have been returned to Baxter.
Initiated
2026-08-03
Root cause
Device Design
Distribution
US Nationwide distribution in the states of Colorado and Florida.
Recall number
Z-3257-2026
Recall status
Open, Classified
CDRH record ID
222192
FDA classified
2026-09-23
Recall event number
99681
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.